Pfizer to supply pneumococcal conjugate vaccines for infants and children
Links shared publicly online about this topic.
- 1,291total visits
Pfizer to supply pneumococcal conjugate vaccines for infants and children
View full resource at news-medical.net
Tags: Vaccination, Meningitis, Pneumococcal Disease, Pneumococcal Vaccine, Disease and Condition, Children's Health, Vaccine, Pfizer
Most Recently Shared on March 24, 2010 at 5:16 pm By:
Meningitis News: Pfizer to supply pneumococcal conjugate vaccines for infants and children: Pfizer Inc. today anno... http://bit.ly/coSs8Q
Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease
news-medical.net — “Pfizer Inc. today announced it has entered into a second supply agreement which will broaden and extend the duration of the Company's commitment to help protect millions of infants and young children in the developing world from pneumococcal disease - the leading cause of vaccine-preventable death in young children.” View full resource at news-medical.net
Most Recently Shared on December 17, 2011 at 8:43 am By:
Meningitis News: Pfizer enters Prevenar 13 supply agreement to protect children from pneumococcal disease: Pfize... http://t.co/7rLrgGvl
Kids' Pneumococcal Vaccine Elicits Response in Adults - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The pneumococcal 13-valent conjugate vaccine (Prevnar 13) -- which is approved for infants and children younger than 6 -- was immunogenic in adults 50 and older, Pfizer announced.” View full resource at qualitypointtech.net
Most Recently Shared on May 9, 2011 at 8:45 pm By:
Kids' Pneumococcal Vaccine Elicits Response in Adults: (MedPage Today) -- The pneumococcal 13-valent conjugate va... http://bit.ly/iFoB8K
WHO grants prequalification to Prevenar 13, Pfizer's 13-valent pneumococcal conjugate vaccine for infants & young children - Biotechnology
pharmabiz.com — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks” View full resource at pharmabiz.com
Most Recently Shared on August 24, 2010 at 11:13 am By:
WHO grants prequalification to Prevenar 13, Pfizer's 13-valent pneumococcal conjugate vaccine for infants & young ... http://bit.ly/an8GLZ
Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification
news-medical.net — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.” View full resource at news-medical.net
Most Recently Shared on August 24, 2010 at 5:19 am By:
Meningitis News: Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The Wor... http://bit.ly/d3rUrU
Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification
news-medical.net — “The World Health Organization (WHO) has granted prequalification to Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed])for active immunization of infants and children from 6 weeks through five years of age against invasive disease, pneumonia and otitis media caused by the 13 pneumococcal serotypes (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F) contained in the vaccine.” View full resource at news-medical.net
Most Recently Shared on August 24, 2010 at 5:13 am By:
Pfizer's Prevenar pneumococcal 13-valent conjugate vaccine receives WHO prequalification: The World Health Organiz... http://bit.ly/c8uCg5
World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children - Aug 23, 2010
pfizer.mediaroom.com — “World Health Organization Grants Prequalification to Prevenar 13*, Pfizer's 13-valent Pneumococcal Conjugate Vaccine for Infants and Young Children - Aug 23, 2010” View full resource at pfizer.mediaroom.com
Most Recently Shared on August 23, 2010 at 4:08 pm By:
Latest news from Pfizer: http://bit.ly/9vPfUt
Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children
medicalnewstoday.com — “Pfizer Inc. (NYSE:PFE) announced today that the United States Food and Drug Administration (FDA) has granted approval for Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CR” View full resource at medicalnewstoday.com
Most Recently Shared on February 26, 2010 at 2:16 pm By:
MNT Pediatrics News Pediatrics and Health News
Pfizer Receives FDA Approval For Prevnar 13™ For The Prevention Of Invasive Pneumococcal Disease In Infants And ... http://mnt.to/3y8Z
Advertisement
